Phyxiom

Phyxiom is a Dublin-based, clinical-stage digital diagnostics company spun out from the Royal College of Surgeons in Ireland (RCSI). It has developed a clinically validated, algorithm-driven software platform that integrates data from smart inhalers and spirometry to offer decision support for physicians managing asthma and COPD. The platform aims to improve diagnostic accuracy, personalize treatment, and reduce steroid burden and hospitalizations. Founded in 2018, the company is led by a team with deep clinical and commercial software expertise and appears to be in an early commercial or pilot launch phase.

A patented software and algorithm platform that integrates data from smart inhalers and spirometry devices. It performs time-based trend analysis to unmask treatment effectiveness, serving as an intelligent clinical decision support system for physicians managing chronic respiratory disease.

Phyxiom competes in the digital therapeutics and remote patient monitoring space for respiratory diseases. Competitors range from simple smart inhaler adherence apps (e.g., from Propeller Health, now part of ResMed) to more comprehensive disease management platforms. Phyxiom's key differentiator is its strong foundation in clinician-led design and validation through multiple randomized controlled trials, positioning it as a clinical decision support tool rather than just a patient engagement app.